Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

BP Levels and Risk of Adverse Renal Events in T1D

Diabetes Care; ePub 2016 Nov 21; Ku, et al

Patients with type 1 diabetes who have a lower blood pressure (BP) of <120/70 mmHg had a substantially lower risk of adverse renal outcomes, regardless of the prior assigned glycemic control strategy, a recent study found. Researchers studied 1,441 participants with type 1 diabetes aged 13 to 39 years who had previously been randomized to receive intensive vs conventional glycemic control in the Diabetes Control and Complications Trial (DCCT). They found:

  • There were 84 cases of stage III chronic kidney disease (CKD) and 169 cases of macroalbuminuria during median follow-up of 24 years.
  • Systolic BP (SBP) in the <120 mmHg ranges was associated with a 0.59 times risk of macroalbuminuria and a 0.32 times risk of stage III CKD compared with SBPs between 130 and 140 mmHg.
  • Diastolic BP (DBP) in the <70 mmHg ranges were associated with a 0.73 times risk of macroalbuminuria and a 0.47 times risk of stage III CKD compared to DBPs between 80 and 90 mmHg.

Citation:

Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu C. Association between blood pressure and adverse renal events in type 1 diabetes. [Published online ahead of print November 21, 2016]. Diabetes Care. doi:10.2337/dc16-0857.